Thomson Reuters StreetEvents via Yahoo
Q3 2024 DiaMedica Therapeutics Inc Earnings Call
Our research and development expenses increased to $5 million for the 3 months ended September 30, 2024...increased manufacturing development activity. These increases were ...
5 days ago